LungCAD_NN :_: a_DT clinically_RB approved_VBN ,_, machine_NN learning_NN system_NN for_IN lung_NN cancer_NN detection_NN
We_PRP present_VBP LungCAD_NN ,_, a_DT computer_NN aided_VBN diagnosis_NN -LRB-_-LRB- CAD_NN -RRB-_-RRB- system_NN that_WDT employs_VBZ a_DT classification_NN algorithm_NN for_IN detecting_VBG solid_JJ pulmonary_JJ nodules_NNS from_IN CT_NN thorax_NN studies_NNS ._.
We_PRP briefly_RB describe_VBP some_DT of_IN the_DT machine_NN learning_NN techniques_NNS developed_VBD to_TO overcome_VB the_DT real_JJ world_NN challenges_NNS in_IN this_DT medical_JJ domain_NN ._.
The_DT most_RBS significant_JJ hurdle_NN in_IN transitioning_VBG from_IN a_DT machine_NN learning_NN research_NN prototype_NN that_WDT performs_VBZ well_RB on_IN an_DT in-house_JJ dataset_NN into_IN a_DT clinically_RB deployable_JJ system_NN ,_, is_VBZ the_DT requirement_NN that_IN the_DT CAD_NN system_NN be_VB tested_VBN in_IN a_DT clinical_JJ trial_NN ._.
We_PRP describe_VBP the_DT clinical_JJ trial_NN in_IN which_WDT LungCAD_NN was_VBD tested_VBN :_: a_DT large_JJ scale_NN multi-reader_JJ ,_, multi-case_JJ -LRB-_-LRB- MRMC_NN -RRB-_-RRB- retrospective_JJ observational_JJ study_NN to_TO evaluate_VB the_DT effect_NN of_IN CAD_NN in_IN clinical_JJ practice_NN for_IN detecting_VBG solid_JJ pulmonary_JJ nodules_NNS from_IN CT_NN thorax_NN studies_NNS ._.
The_DT clinical_JJ trial_NN demonstrates_VBZ that_IN every_DT radiologist_NN that_WDT participated_VBD in_IN the_DT trial_NN had_VBD a_DT significantly_RB greater_JJR accuracy_NN with_IN LungCAD_NN ,_, both_DT for_IN detecting_VBG nodules_NNS and_CC identifying_VBG potentially_RB actionable_JJ nodules_NNS ;_: this_DT ,_, along_IN with_IN other_JJ findings_NNS from_IN the_DT trial_NN ,_, has_VBZ resulted_VBN in_IN FDA_NNP approval_NN for_IN LungCAD_NN in_IN late_JJ 2006_CD ._.
TL_NN produced_VBD reasonable_JJ classifiers_NNS for_IN each_DT task_NN ,_, it_PRP could_MD not_RB delete_VB all_DT irrelevant_JJ features_NNS using_VBG data_NNS available_JJ for_IN each_DT single_JJ task_NN ._.
6.2_CD Lung_NN Cancer_NNP Data_NNP A_NNP prototype_NN version_NN of_IN our_PRP$ lungCAD_NN system_NN =_JJ -_: =[_NN 16_CD -RRB-_-RRB- -_: =_JJ -_: -LRB-_-LRB- not_RB commercially_RB available_JJ -RRB-_-RRB- was_VBD applied_VBN on_IN a_DT proprietary_JJ anonymized_JJ patient_NN data_NNS set_VBD collected_VBN from_IN multiple_JJ normalized_VBN vector_NN value_NN 0.8_CD 0.7_CD 0.6_CD 0.5_CD 0.4_CD 0.3_CD 0.2_CD 0.1_CD 0_CD task_NN 1_CD task_NN 2_CD task_NN 3_CD c_NN normaliz_NN
ed_VBN within_IN the_DT lung_NN ,_, the_DT 5-year_JJ survival_NN rate_NN is_VBZ 49_CD %_NN ,_, and_CC many_JJ treatment_NN options_NNS -LRB-_-LRB- surgery_NN ,_, radiotherapy_NN ,_, chemotherapy_NN -RRB-_-RRB- are_VBP viable_JJ ._.
Today_NN ,_, only_RB 24_CD %_NN of_IN lung_NN cancer_NN cases_NNS are_VBP diagnosed_VBN at_IN an_DT early_JJ stage_NN ._.
=_SYM -_: =[_NN 1_CD ,_, 10_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT recent_JJ development_NN of_IN multidetector_JJ computed_JJ tomography_NN -LRB-_-LRB- MDCT_NN -RRB-_-RRB- scanners_NNS has_VBZ made_VBN it_PRP feasible_JJ to_TO detect_VB lung_NN cancer_NN at_IN very_RB early_JJ stages_NNS in_IN priciple_NN ._.
Despite_IN these_DT advances_NNS in_IN technology_NN ,_, many_JJ po_NN
interest_NN -LRB-_-LRB- ROI_NN -RRB-_-RRB- from_IN a_DT medical_JJ image_NN ;_: 3_CD ._.
feature_NN extraction_NN that_WDT computes_VBZ descriptive_JJ features_NNS for_IN each_DT candidate_NN so_IN that_IN each_DT candidate_NN is_VBZ represented_VBN by_IN a_DT vector_NN x_NN of_IN numerical_JJ values_NNS or_CC attributes_VBZ =_JJ -_: =[_NN 15_CD -RRB-_-RRB- -_: =_JJ -_: ;_: 4_CD ._.
classification_NN that_WDT differentiates_VBZ candidates_NNS based_VBN on_IN candidate_NN feature_NN vectors_NNS ;_: 5_CD ._.
visual_JJ presentation_NN of_IN CAD_NN findings_NNS to_TO the_DT radiologist_NN in_IN order_NN for_IN him_PRP to_TO accept_VB or_CC reject_VB the_DT CAD_NNP findings_NNS ._.
em_NN has_VBZ to_TO satisfy_VB real-time_JJ requirements_NNS that_IN it_PRP finishes_VBZ running_VBG during_IN the_DT radiologists_NNS first_JJ read_NN ._.
These_DT issues_NNS were_VBD addressed_VBN by_IN employing_VBG effective_JJ cascaded_JJ classification_NN frameworks_NNS as_IN shown_VBN in_IN =_JJ -_: =[_NN 4_CD ,_, 5_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT method_NN in_IN -LRB-_-LRB- 4_CD -RRB-_-RRB- investigates_VBZ a_DT cascaded_JJ classification_NN approach_NN that_WDT solves_VBZ a_DT sequence_NN of_IN linear_JJ programs_NNS ,_, each_DT constructing_VBG a_DT sparse_JJ hyperplane_NN -LRB-_-LRB- linear_NN -RRB-_-RRB- classifier_NN ._.
It_PRP incorporates_VBZ the_DT computatio_NN
erator_NN ,_, both_CC the_DT features_NNS and_CC the_DT class_NN labels_NNS of_IN several_JJ adjacent_JJ candidates_NNS are_VBP highly_RB correlated_VBN ._.
This_DT is_VBZ true_JJ both_CC in_IN the_DT training_NN set_NN and_CC in_IN the_DT testing_NN data_NNS ._.
A_DT batch-classification_JJ algorithm_NN in_IN =_JJ -_: =[_NN 14_CD -RRB-_-RRB- -_: =_SYM -_: derives_VBZ a_DT probabilistic_JJ classification_NN model_NN by_IN specifying_VBG a_DT priori_FW guess_NN on_IN the_DT candidate_NN labels_VBZ with_IN a_DT covariance_NN matrix_NN Σ_NN that_WDT encodes_VBZ the_DT spatial-proximity-based_JJ correlations_NNS within_IN an_DT image_NN ._.
Mul_NN
st_IN to_TO associate_VB with_IN a_DT single_JJ malignant_JJ structure_NN ._.
Random_JJ effects_NNS may_MD exist_VB in_IN patient_NN images_NNS from_IN the_DT same_JJ hospital_NN ,_, or_CC exist_VBP in_IN different_JJ candidates_NNS extracted_VBN from_IN the_DT same_JJ patient_NN ._.
The_DT approach_NN in_IN =_JJ -_: =[_NN 7_CD -RRB-_-RRB- -_: =_SYM -_: proposes_VBZ to_TO use_VB additional_JJ mix-effect_JJ parameters_NNS ,_, each_DT for_IN one_CD hospital_NN ,_, or_CC for_IN one_CD patient_NN ._.
All_DT these_DT algorithms_NNS improve_VBP the_DT classification_NN accuracy_NN significantly_RB ._.
Unbalanced_JJ Data_NN and_CC Speed_NN In_IN the_DT c_NN
a_DT second_JJ reader_NN -LRB-_-LRB- i.e._FW ,_, in_IN conjunction_NN with_IN the_DT radiologist_NN -RRB-_-RRB- not_RB only_RB offers_VBZ the_DT potential_NN to_TO improve_VB the_DT detection_NN accuracy_NN of_IN a_DT radiologist_NN ,_, but_CC also_RB to_TO reduce_VB mistakes_NNS related_VBN to_TO misinterpretation_NN =_JJ -_: =[_NN 2_CD ,_, 11_CD -RRB-_-RRB- -_: =_SYM -_: ._.
In_IN order_NN for_IN a_DT CAD_NN system_NN to_TO be_VB used_VBN in_IN clinical_JJ practice_NN in_IN the_DT United_NNP States_NNPS ,_, it_PRP must_MD first_RB receive_VB approval_NN from_IN the_DT the_DT Food_NNP and_CC Drug_NNP Administration_NNP -LRB-_-LRB- FDA_NNP -RRB-_-RRB- ._.
All_DT CAD_NNP systems_NNS must_MD go_VB through_IN a_DT rigo_NN
rom_VB the_DT feature_NN set_NN according_VBG to_TO certain_JJ discriminant_JJ score_NN ranking_NN ._.
Recent_JJ research_NN has_VBZ focused_VBN more_RBR on_IN general_JJ sparsity_NN treatments_NNS to_TO construct_VB sparse_JJ estimates_NNS of_IN classifier_NN parameters_NNS ,_, such_JJ as_IN in_IN =_JJ -_: =[_NN 6_CD ,_, 4_CD -RRB-_-RRB- -_: =_SYM -_: ._.
These_DT models_NNS control_VBP the_DT classifier_NN complexity_NN by_IN sparse-favoring_JJ regularization_NN terms_NNS ,_, such_JJ as_IN the_DT ℓ1-norm_JJ regularization_NN |_NNP |_NNP w_NNP |_NNP |_NNP 1_CD =_JJ |_FW wi_FW |_NN for_IN a_DT linear_JJ classifier_NN of_IN the_DT form_NN sign_NN -LRB-_-LRB- w_NN T_NN x_NN -RRB-_-RRB- ._.
3_LS ._.
LUNGCAD_NN
ed_VBN within_IN the_DT lung_NN ,_, the_DT 5-year_JJ survival_NN rate_NN is_VBZ 49_CD %_NN ,_, and_CC many_JJ treatment_NN options_NNS -LRB-_-LRB- surgery_NN ,_, radiotherapy_NN ,_, chemotherapy_NN -RRB-_-RRB- are_VBP viable_JJ ._.
Today_NN ,_, only_RB 24_CD %_NN of_IN lung_NN cancer_NN cases_NNS are_VBP diagnosed_VBN at_IN an_DT early_JJ stage_NN ._.
=_SYM -_: =[_NN 1_CD ,_, 10_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT recent_JJ development_NN of_IN multidetector_JJ computed_JJ tomography_NN -LRB-_-LRB- MDCT_NN -RRB-_-RRB- scanners_NNS has_VBZ made_VBN it_PRP feasible_JJ to_TO detect_VB lung_NN cancer_NN at_IN very_RB early_JJ stages_NNS in_IN priciple_NN ._.
Despite_IN these_DT advances_NNS in_IN technology_NN ,_, many_JJ po_NN
ication_NN model_NN by_IN specifying_VBG a_DT priori_FW guess_NN on_IN the_DT candidate_NN labels_VBZ with_IN a_DT covariance_NN matrix_NN Σ_NN that_WDT encodes_VBZ the_DT spatial-proximity-based_JJ correlations_NNS within_IN an_DT image_NN ._.
Multiple-instance_JJ learning_NN methods_NNS =_JJ -_: =[_NN 9_CD ,_, 3_CD -RRB-_-RRB- -_: =_SYM -_: optimize_VB the_DT classifier_NN design_NN by_IN taking_VBG into_IN account_NN the_DT fact_NN that_IN multiple_JJ candidates_NNS can_MD exist_VB to_TO associate_VB with_IN a_DT single_JJ malignant_JJ structure_NN ._.
Random_JJ effects_NNS may_MD exist_VB in_IN patient_NN images_NNS from_IN the_DT s_NN
em_NN has_VBZ to_TO satisfy_VB real-time_JJ requirements_NNS that_IN it_PRP finishes_VBZ running_VBG during_IN the_DT radiologists_NNS first_JJ read_NN ._.
These_DT issues_NNS were_VBD addressed_VBN by_IN employing_VBG effective_JJ cascaded_JJ classification_NN frameworks_NNS as_IN shown_VBN in_IN =_JJ -_: =[_NN 4_CD ,_, 5_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT method_NN in_IN -LRB-_-LRB- 4_CD -RRB-_-RRB- investigates_VBZ a_DT cascaded_JJ classification_NN approach_NN that_WDT solves_VBZ a_DT sequence_NN of_IN linear_JJ programs_NNS ,_, each_DT constructing_VBG a_DT sparse_JJ hyperplane_NN -LRB-_-LRB- linear_NN -RRB-_-RRB- classifier_NN ._.
It_PRP incorporates_VBZ the_DT computatio_NN
ful_NN ._.
Additional_JJ details_NNS on_IN the_DT multi-reader_JJ ,_, multi-case_JJ -LRB-_-LRB- MRMC_NN -RRB-_-RRB- statistical_JJ methodology_NN used_VBN ,_, are_VBP provided_VBN in_IN our_PRP$ submission_NN and_CC in_IN -LRB-_-LRB- 16_CD -RRB-_-RRB- ._.
The_DT LungCAD_NN clinical_JJ trial_NN summary_NN of_IN safety_NN and_CC effectiveness_NN =_JJ -_: =[_NN 8_CD -RRB-_-RRB- -_: =_JJ -_: -LRB-_-LRB- which_WDT is_VBZ available_JJ on_IN the_DT FDA_NNP 's_POS web_NN site_NN -RRB-_-RRB- contains_VBZ many_JJ more_JJR results_NNS and_CC analyses_NNS ,_, including_VBG :_: patient-level_JJ analysis_NN of_IN GR_NN 's_POS increase_NN in_IN accuracy_NN with_IN CAD_NN ,_, bootstrap_NN sampling_NN to_TO estimate_VB variability_NN
ication_NN model_NN by_IN specifying_VBG a_DT priori_FW guess_NN on_IN the_DT candidate_NN labels_VBZ with_IN a_DT covariance_NN matrix_NN Σ_NN that_WDT encodes_VBZ the_DT spatial-proximity-based_JJ correlations_NNS within_IN an_DT image_NN ._.
Multiple-instance_JJ learning_NN methods_NNS =_JJ -_: =[_NN 9_CD ,_, 3_CD -RRB-_-RRB- -_: =_SYM -_: optimize_VB the_DT classifier_NN design_NN by_IN taking_VBG into_IN account_NN the_DT fact_NN that_IN multiple_JJ candidates_NNS can_MD exist_VB to_TO associate_VB with_IN a_DT single_JJ malignant_JJ structure_NN ._.
Random_JJ effects_NNS may_MD exist_VB in_IN patient_NN images_NNS from_IN the_DT s_NN
thout_VB CAD_NNP ,_, for_IN detecting_VBG solid_JJ pulmonary_JJ nodules_NNS ,_, is_VBZ the_DT area_NN under_IN ROC_NN curve_NN ,_, using_VBG lobes_NNS as_IN the_DT unit_NN of_IN analysis_NN ._.
A_DT nonparametric_JJ estimator_NN was_VBD used_VBN to_TO adjust_VB for_IN the_DT clustered_VBN data_NNS as_IN described_VBN in_IN =_JJ -_: =[_NN 12_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Sensitivity_NN was_VBD defined_VBN as_IN the_DT probability_NN that_IN a_DT GR_NN identified_VBN at_IN least_JJS one_CD nodule_NN in_IN an_DT affected_JJ lobe_NN ;_: specificity_NN was_VBD defined_VBN as_IN the_DT probability_NN that_IN a_DT GR_NN did_VBD not_RB identify_VB a_DT nodule_NN in_IN a_DT normal_JJ lo_NN
CT_NN -RRB-_-RRB- scanners_NNS has_VBZ made_VBN it_PRP feasible_JJ to_TO detect_VB lung_NN cancer_NN at_IN very_RB early_JJ stages_NNS in_IN priciple_NN ._.
Despite_IN these_DT advances_NNS in_IN technology_NN ,_, many_JJ potentially_RB clinically_RB significant_JJ lesions_NNS still_RB remain_VBP undetected_JJ =_JJ -_: =[_NN 13_CD -RRB-_-RRB- -_: =_SYM -_: ._.
One_CD contributing_JJ factor_NN is_VBZ the_DT explosion_NN of_IN generated_VBN data_NNS :_: The_DT state-of-the-art_JJ 64slice_FW dual-source_FW CT_NN acquires_VBZ up_IN to_TO 3,687_CD axial_JJ images_NNS in_IN 30_CD seconds_NNS for_IN each_DT patient_NN -LRB-_-LRB- each_DT image_NN must_MD then_RB be_VB care_NN
a_DT second_JJ reader_NN -LRB-_-LRB- i.e._FW ,_, in_IN conjunction_NN with_IN the_DT radiologist_NN -RRB-_-RRB- not_RB only_RB offers_VBZ the_DT potential_NN to_TO improve_VB the_DT detection_NN accuracy_NN of_IN a_DT radiologist_NN ,_, but_CC also_RB to_TO reduce_VB mistakes_NNS related_VBN to_TO misinterpretation_NN =_JJ -_: =[_NN 2_CD ,_, 11_CD -RRB-_-RRB- -_: =_SYM -_: ._.
In_IN order_NN for_IN a_DT CAD_NN system_NN to_TO be_VB used_VBN in_IN clinical_JJ practice_NN in_IN the_DT United_NNP States_NNPS ,_, it_PRP must_MD first_RB receive_VB approval_NN from_IN the_DT the_DT Food_NNP and_CC Drug_NNP Administration_NNP -LRB-_-LRB- FDA_NNP -RRB-_-RRB- ._.
All_DT CAD_NNP systems_NNS must_MD go_VB through_IN a_DT rigo_NN
